NCT01916226
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Aventura, Florida, United States
- GSK Investigational Site Miami, Florida, United States